TYBOURNE CAPITAL MANAGEMENT (HK) LTD 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-04 6:21 pm Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,268,086 9.990% | 627,316 (+97.90%) | Filing |
| 2025-02-14 4:33 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 640,770 9.990% | 640,770 (New Position) | Filing |